The current head of the agency, FDA Commissioner Robert Califf, will testify before a congressional committee today that the top levels of the agency weren't aware of the whistleblower's report because of "Mailroom issues."
The FDA had "Mailroom issues."
Up until now FDA officials declined to comment on why it took months between the first report of a bacterial infection linked to the plant last September, their inspection this winter, which turned up a range of food safety problems, and the recall.
There were internal discussions at the FDA about potential supply disruptions.
The FDA timeline laid out in the prepared testimony acknowledges the FDA didn't hold interagency discussions about potential supply chain disruptions until Feb. 14, three days before the Abbott Nutrition plant at the center of the current shortages shut down and issued a formula recall.
Why did it take the FDA until the end of January to begin its inspection of Abbott's Sturgis plant, despite receiving warnings last fall? The FDA blames the staff at Sturgis for delaying their inspection because of COVID-19 staffing issues.
Despite parents screaming for more formula for the first two weeks in May, it wasn't until May 16 that the government reached an agreement with Abbott to reopen its Sturgis plant.
It's becoming increasingly difficult to discern fact from fiction, and unfortunately the media has a strong bias. They spin stories to make conservatives look bad and will go to great lengths to avoid reporting on the good that comes from conservative policies. There are a few shining lights in the media landscape-brave conservative outlets that report the truth and offer a different perspective. We must support conservative outlets like this one and ensure that our voices are heard.
Thursday, May 26, 2022
The Unbelievable Reason for the FDA's Delayed Response to the Formula Crisis
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment